HKG Equity Snapshot

2617 Weekly Equity Report

TransThera Sciences (Nanjing), Inc.

Latest Close 32.14 HKD 12 Jun 2026
1W Return 1.8% latest completed week
4W Return -33.8% short-term follow-through
12W Return -53.1% quarterly tape
Trend Breadth 0.0% 0 of 51 weeks active
Volume Ratio 1.3x vs 13-week average
Company Brief

What the company does

TransThera Sciences (Nanjing), Inc., clinical stage pharmaceutical company company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases. The company provides Tinengotinib (TT-00420), a multi-kinase inhibitor that is in clinical stage for the treatment of recurrent or refractory drug-resistant solid tumors. It also develops TT-00973, a kinase inhibitor for treating various cancers; TT-01488, a BTK inhibitor for the treatment of B-cell lymphoma; TT-01688, an oral S1P1 modulator for treating various inflammatory diseases; TT-00920, an oral PDE9 inhibitor used for treating central nervous system diseases; TT-01025, an oral irreversible VAP-1 inhibitor designed …

Snapshot

What the weekly tape is saying

2617 closed the latest completed week at 32.14 HKD. The 4-week return is -33.8% and the 12-week return is -53.1%. Trend Signal is inactive, Market Dynamics is -0.59. Setup signature: Risk-first tape with a 21/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -64.1%
Volume 1.3x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 0 Persistence of active Trend Signal over the last year and current streak.
Momentum 0 Blend of 4-week and 12-week follow-through.
Dynamics 24 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 50 Relative leadership and short-term RS change.
Volume 53 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
89.54 HKD
Vs Trend Line
-64.1%
Fair Value
96.03 HKD
Vs Fair Value
-66.5%
52W High
679.5 HKD
52W Low
20.20 HKD
Drawdown
-95.3%
Range Position
1.8%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 1.8%
4W -33.8%
12W -53.1%
26W -80.0%
52W -

Trend read

Active Streak
0 weeks
52W Active Weeks
0
52W Active Breadth
0.0%
Sector Scope
HK Healthcare
Sector Rank
62 of 257
Sector Percentile
76.2%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.59
4W MD Change
-194.9%
Relative Strength
-
4W RS Change
-
Expectation
Negative
Probability
35.92%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
9.5M
13W Average
7.6M
52W Average
8.9M
Vs 13W
1.3x
Vs 52W
1.1x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
7.7%
52W Volatility
32.7%
Upside Weeks
21
Downside Weeks
29
Downside Breadth
58.0%
Avg Gain / Loss
21.4% / -10.0%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
HKG
Country
HK
Sector
Healthcare
Industry
Biotechnology
Currency
HKD
Market Cap
14.6B

Opportunity signals

  • No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 32.14 HKD 1.8% 89.54 HKD 96.03 HKD -0.59 - 9.5M Off
5 Jun 2026 31.58 HKD -9.8% 95.27 HKD 97.30 HKD -0.40 - 7.7M Off
29 May 2026 35.02 HKD -18.3% 101.6 HKD 98.65 HKD -0.27 - 8.5M Off
22 May 2026 42.84 HKD -11.8% 106.5 HKD 99.97 HKD -0.22 - 8.3M Off
15 May 2026 48.58 HKD -12.0% 111.5 HKD 101.2 HKD -0.20 - 8.9M Off
8 May 2026 55.20 HKD 7.0% 116.6 HKD 102.3 HKD -0.21 - 13.2M Off
1 May 2026 51.60 HKD -11.9% 118.8 HKD 103.4 HKD -0.30 - 5.9M Off
24 Apr 2026 58.60 HKD -15.3% 121.6 HKD 104.6 HKD -0.39 - 5.8M Off
17 Apr 2026 69.20 HKD 0.9% 124.4 HKD 105.6 HKD -0.53 - 5.3M Off
10 Apr 2026 68.60 HKD -2.1% 127.1 HKD 106.5 HKD -0.68 - 2.9M Off
3 Apr 2026 70.10 HKD 0.3% 131.2 HKD 107.4 HKD -0.77 - 6.5M Off
27 Mar 2026 69.90 HKD 1.9% 131.0 HKD 108.3 HKD -0.79 - 7.1M Off
20 Mar 2026 68.60 HKD -10.5% 130.5 HKD 109.3 HKD -0.87 - 8.6M Off
13 Mar 2026 76.65 HKD -16.7% 130.0 HKD 110.4 HKD -0.96 - 30.8M Off